Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction

NCT03492242 · clinicaltrials.gov ↗

COMPLETED

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Arthritis
Cancer
Cardiac Disease
Endocrine System Diseases
Autoimmune Diseases
Ophthalmopathy
Myositis
Neuropathy

Interventions

DRUG: Immune checkpoint inhibitor

Sponsor

Groupe Hospitalier Pitie-Salpetriere

Collaborators

[object Object]